Daiwa Securities Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Daiwa Securities Group’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,369	Closed	-$2K	–	1398
2025 Q3	$2K	Hold	1,369	–	–	﹤0.01%	1275
2025 Q2	$1K	Hold	1,369	–	–	﹤0.01%	1267
2025 Q1	$1K	Hold	1,369	–	–	﹤0.01%	1232
2024 Q4	$1K	Hold	1,369	–	–	﹤0.01%	1256
2024 Q3	$2K	Hold	1,369	–	–	﹤0.01%	1221
2024 Q2	$2K	Buy	1,369 +935	+215%	+$1.68K	﹤0.01%	1253
2024 Q1	$1K	Hold	434	–	–	﹤0.01%	1297
2023 Q4	$1K	Hold	434	–	–	﹤0.01%	1300
2023 Q3	$0	Hold	434	–	–	﹤0.01%	1318
2023 Q2	$1K	Hold	434	–	–	﹤0.01%	1282
2023 Q1	$1K	Hold	434	–	–	﹤0.01%	1262
2022 Q4	$1K	Hold	434	–	–	﹤0.01%	1277
2022 Q3	$1K	Hold	434	–	–	﹤0.01%	1299
2022 Q2	$1K	Hold	434	–	–	﹤0.01%	1299
2022 Q1	$1K	Hold	434	–	–	﹤0.01%	1317
2021 Q4	$2K	Buy	+434	New	+$2.11K	﹤0.01%	1287
2020 Q4	–	Sell	-583	Closed	-$1K	–	1281
2020 Q3	$1K	Hold	583	–	–	﹤0.01%	1165
2020 Q2	$1K	Hold	583	–	–	﹤0.01%	1188
2020 Q1	$1K	Hold	583	–	–	﹤0.01%	1191
2019 Q4	$2K	Hold	583	–	–	﹤0.01%	1162
2019 Q3	$2K	Hold	583	–	–	﹤0.01%	1129
2019 Q2	$4K	Hold	583	–	–	﹤0.01%	1117
2019 Q1	$3K	Hold	583	–	–	﹤0.01%	1107
2018 Q4	$4K	Hold	583	–	–	﹤0.01%	1073
2018 Q3	$6K	Hold	583	–	–	﹤0.01%	1072
2018 Q2	$7K	Hold	583	–	–	﹤0.01%	1072
2018 Q1	$5K	Buy	+583	New	+$5.39K	﹤0.01%	1074

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Daiwa Securities Group's LXRX Position: Q4 2025 in Review

Daiwa Securities Group sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2025, closing a stake of 1,369 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in LXRX in Q1 2018 and held it in 27 quarters. The position peaked at $7K in Q2 2018. 125 funds tracked by Wall St. Rank hold LXRX as of Q4 2025.

Daiwa Securities Group reported no remaining Lexicon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Daiwa Securities Group sold 1,369 Lexicon Pharmaceuticals shares in Q4 2025, an estimated $2K.
Daiwa Securities Group first reported a position in Lexicon Pharmaceuticals in Q1 2018 and held it in 27 quarters.
Daiwa Securities Group's Lexicon Pharmaceuticals position peaked at $7K in Q2 2018.
125 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2025.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.